Assessment of ability of human adipose derived stem cells for long term overexpression of IL-11 and IL-13 as therapeutic cytokines.
Human adipose derived stem cell (hADSC)
Interleukin11
Interleukin13
Lentiviral vector
Overexpression
Journal
Cytotechnology
ISSN: 0920-9069
Titre abrégé: Cytotechnology
Pays: United States
ID NLM: 8807027
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
22
06
2020
accepted:
02
09
2020
pubmed:
17
9
2020
medline:
17
9
2020
entrez:
16
9
2020
Statut:
ppublish
Résumé
Adipose-derived stem cells (ADSCs) are a type of mesenchymal stem cells with the therapeutic effects that make them one of the best sources for cell therapy. In this study, we aimed to assess the ability of human ADSCs for constant expression of IL-11 and IL-13, simultaneously. In this study, the characterized hADSCs were transduced with a lentiviral vector (PCDH-513B) containing IL-11 and IL-13 genes, and the ability of long-term expression of the transgenes was evaluated by ELISA technique on days 15, 45 and 75 after transduction. Our results indicated a high rate of transduction (more than 90%) in the isolated hADSCs. Our data showed the highest rate of expression on days 75 after transduction which was 242.67 pg/ml for IL-11 and 303.6 pg/ml for IL-13 compared with 35.2 pg/ml and 35.6 pg/ml in untreated cells, respectively (p = 0.001). Besides, MTT assay showed transduction of hADSCs with lentiviral viruses containing IL-11 and IL-13 had no adverse effect on hADSCs proliferation (p-value = 0.89). Finally, we successfully constructed a hADSC population stably overexpressing IL-11 as the neurotrophic cytokine and IL-13 as the anti-inflammatory cytokine and this transduced cells can be used for further studies in EAE mice model.
Identifiants
pubmed: 32935166
doi: 10.1007/s10616-020-00421-8
pii: 10.1007/s10616-020-00421-8
pmc: PMC7547926
doi:
Types de publication
Journal Article
Langues
eng
Pagination
773-784Subventions
Organisme : Isfahan University of Medical Sciences
ID : 397053
Références
Nat Commun. 2015 Mar 13;6:6532
pubmed: 25766071
Brain Sci. 2016 Jun 13;6(2):
pubmed: 27304970
Exp Ther Med. 2017 Mar;13(3):1039-1043
pubmed: 28450938
Stem Cell Reports. 2016 Dec 13;7(6):1099-1115
pubmed: 27974221
Int J Cell Biol. 2018 Dec 19;2018:8213912
pubmed: 30662466
Mol Ther. 2000 Aug;2(2):170-6
pubmed: 10947945
Stem Cells. 2008 Jul;26(7):1713-22
pubmed: 18436861
Brain Sci. 2017 Jul 07;7(7):
pubmed: 28686222
Int J Mol Sci. 2012;13(8):10647-10659
pubmed: 22949885
Cell Adh Migr. 2012 May-Jun;6(3):179-89
pubmed: 22568986
Neurotherapeutics. 2019 Oct;16(4):1304-1319
pubmed: 31372938
Int J Mol Sci. 2019 May 22;20(10):
pubmed: 31121953
J Microbiol Methods. 2007 Dec;71(3):212-9
pubmed: 17897741
Mediators Inflamm. 2013;2013:685317
pubmed: 23818742
Eur J Cell Biol. 2019 Dec;98(5-8):151041
pubmed: 31023504
J Med Life. 2015 Jan-Mar;8(1):24-7
pubmed: 25914733
Methods Mol Biol. 2011;702:345-57
pubmed: 21082414
J Immunol. 2008 Jul 15;181(2):954-68
pubmed: 18606647
Biomedicines. 2019 Mar 30;7(2):
pubmed: 30935074
Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):856-65
pubmed: 23017834
Curr Protoc Neurosci. 2010 Oct;Chapter 4:Unit 4.21
pubmed: 20938923
Clin Exp Immunol. 2014 Mar;175(3):425-38
pubmed: 24134716
Immunology. 2014 Mar;141(3):302-13
pubmed: 23981039
Glia. 2016 Dec;64(12):2181-2200
pubmed: 27685637
J Neurosci. 2006 Nov 22;26(47):12174-85
pubmed: 17122042
Adv Immunol. 2008;98:121-49
pubmed: 18772005
Methods Mol Biol. 2016;1416:149-58
pubmed: 27236670
Cytotechnology. 2016 Oct;68(5):2049-60
pubmed: 26815002
Cell Mol Life Sci. 2008 Sep;65(17):2702-20
pubmed: 18516496
Mol Vis. 2007 May 23;13:758-63
pubmed: 17563726
Brain Behav Immun. 2013 May;30:103-14
pubmed: 23369732
Rev Bras Hematol Hemoter. 2013;35(1):62-7
pubmed: 23580887
Stem Cells. 2009 Oct;27(10):2624-35
pubmed: 19676124
J Immunol. 2009 Oct 1;183(7):4229-40
pubmed: 19734214
CMAJ. 2014 Aug 5;186(11):833-40
pubmed: 24756629
J Am Coll Dent. 2014 Summer;81(3):14-8
pubmed: 25951678
Stem Cell Res Ther. 2015 Jan 07;6:5
pubmed: 25567327
Int J Mol Sci. 2017 Aug 25;18(9):
pubmed: 28841158
Clin Rev Allergy Immunol. 2017 Apr;52(2):234-259
pubmed: 27207172
Mol Neurobiol. 2017 Dec;54(10):8071-8089
pubmed: 27889895
Drugs. 2013 Dec;73(18):2017-29
pubmed: 24242317
FEBS Lett. 2011 Dec 1;585(23):3813-20
pubmed: 21864535